NO20003287D0 - FremgangsmÕte for Õ utvikle, teste og anvende assosieringer av makromolekyler og kompleksaggregater for forbedret last og regulerbare de/assosieringshastigheter - Google Patents

FremgangsmÕte for Õ utvikle, teste og anvende assosieringer av makromolekyler og kompleksaggregater for forbedret last og regulerbare de/assosieringshastigheter

Info

Publication number
NO20003287D0
NO20003287D0 NO20003287A NO20003287A NO20003287D0 NO 20003287 D0 NO20003287 D0 NO 20003287D0 NO 20003287 A NO20003287 A NO 20003287A NO 20003287 A NO20003287 A NO 20003287A NO 20003287 D0 NO20003287 D0 NO 20003287D0
Authority
NO
Norway
Prior art keywords
associations
macromolecules
developing
testing
adjustable
Prior art date
Application number
NO20003287A
Other languages
English (en)
Other versions
NO20003287L (no
Inventor
Gregor Cevc
Original Assignee
Idea Innovat Dermale Appl Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idea Innovat Dermale Appl Gmbh filed Critical Idea Innovat Dermale Appl Gmbh
Publication of NO20003287D0 publication Critical patent/NO20003287D0/no
Publication of NO20003287L publication Critical patent/NO20003287L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20003287A 1998-10-23 2000-06-22 FremgangsmÕte for Õ utvikle, teste og anvende assosieringer av makromolekyler og kompleksaggregater for forbedret last og regulerbare dissosierings-/assosieringshastigheter NO20003287L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1998/006750 WO2000024377A1 (en) 1998-10-23 1998-10-23 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates

Publications (2)

Publication Number Publication Date
NO20003287D0 true NO20003287D0 (no) 2000-06-22
NO20003287L NO20003287L (no) 2000-08-23

Family

ID=8167110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003287A NO20003287L (no) 1998-10-23 2000-06-22 FremgangsmÕte for Õ utvikle, teste og anvende assosieringer av makromolekyler og kompleksaggregater for forbedret last og regulerbare dissosierings-/assosieringshastigheter

Country Status (12)

Country Link
US (2) US20080279815A1 (no)
EP (1) EP1039880A1 (no)
JP (1) JP4838936B2 (no)
KR (1) KR100464601B1 (no)
CN (1) CN1192766C (no)
AU (1) AU765385C (no)
BR (1) BR9814415A (no)
CA (1) CA2309633C (no)
HU (1) HUP0102741A3 (no)
MX (1) MXPA00006196A (no)
NO (1) NO20003287L (no)
WO (1) WO2000024377A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1031347T1 (en) 1999-01-27 2002-10-31 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
PT1031346E (pt) 1999-01-27 2002-09-30 Idea Ag Vacinacao nao invasiva atraves da pele
WO2001001962A1 (en) 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
DE10114244A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
GB2398495B (en) * 2003-01-23 2007-08-22 Kent G Lau A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug
UA75030C2 (en) * 2005-11-30 2006-03-15 Viktor Oleksandrovych Bykov Method for obtaining stable aqueous solutions of drugs
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
US8962015B2 (en) 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
CN102512667B (zh) * 2010-07-14 2015-08-19 中国医学科学院药物研究所 一种胰岛素的脂质复合物及其制备方法和制剂
US8422540B1 (en) 2012-06-21 2013-04-16 CBF Networks, Inc. Intelligent backhaul radio with zero division duplexing
KR101849441B1 (ko) 2015-03-19 2018-04-16 김태구 캔 오프너
KR20160112915A (ko) 2015-10-23 2016-09-28 김태구 캔 오프너
WO2017087685A1 (en) * 2015-11-20 2017-05-26 The Regents Of The University Of California Deformable nano-scale vehicles (dnvs) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery
JP7306718B2 (ja) * 2017-03-13 2023-07-11 エスディージー インコーポレイテッド 向上した安定性を有する脂質ベースのナノ粒子
CA3058782A1 (en) * 2017-04-03 2018-10-11 The Regents Of The University Of California Deformable nano-scale vehicles (dnvs) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery
US11564392B2 (en) 2017-09-18 2023-01-31 Bayer Healthcare Llc Methods of inactivation of viruses using n-methlyglucamide and its derivatives
CN112533478A (zh) * 2018-08-08 2021-03-19 3M创新有限公司 治疗组合物和相关方法
KR20220118210A (ko) * 2021-02-18 2022-08-25 (주)아모레퍼시픽 트랜스퍼좀을 포함하는 난용성 효능물질 전달체
CN115350330B (zh) * 2022-09-01 2023-10-20 北京化工大学 一种负电性小分子调控的表面在蛋白差异性黏附上的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US5008050A (en) * 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US4897269A (en) * 1984-09-24 1990-01-30 Mezei Associates Limited Administration of drugs with multiphase liposomal delivery system
US4937182A (en) * 1985-12-19 1990-06-26 Peralta Cancer Research Institute Method for predicting chemosensitivity of anti-cancer drugs
US5244678A (en) * 1986-01-14 1993-09-14 Ire-Celltarg S.A. Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic encapsulated in liposomes
KR900007831B1 (ko) * 1986-11-28 1990-10-20 더 리포조옴 캄파니, 인코포레이티드 인지질 조성물
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
US5043165A (en) * 1988-12-14 1991-08-27 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
EP0384040B1 (en) * 1989-02-24 1994-01-26 Agfa-Gevaert N.V. Dye-donor element for thermal dye sublimation transfer
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
WO1992003122A1 (de) * 1990-08-24 1992-03-05 Gregor Cevc Präparat zur wirkstoffapplikation in kleinsttröpfchenform
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
JP2922017B2 (ja) * 1991-03-25 1999-07-19 第一製薬株式会社 経口用脂質膜構造体
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
GB9116610D0 (en) * 1991-08-01 1991-09-18 Danbiosyst Uk Preparation of microparticles
EG20380A (en) * 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
EP0608320B1 (en) * 1991-10-16 1998-01-28 Richardson-Vicks, Inc. Enhanced skin penetration system for improved topical delivery of drugs
CA2139757C (en) * 1992-07-08 2009-04-14 Gunther Maierhofer Liposomes, method of preparing the same and use thereof in the preparation of drugs
AU4673993A (en) * 1992-07-28 1994-02-14 Procter & Gamble Company, The Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
US5460820B1 (en) * 1993-08-03 1999-08-03 Theratech Inc Method for providing testosterone and optionally estrogen replacement therapy to women
US6027726A (en) * 1994-09-30 2000-02-22 Inex Phamaceuticals Corp. Glycosylated protein-liposome conjugates and methods for their preparation
DE69532622T2 (de) * 1994-12-07 2005-02-03 Tokyo Cosmos Electric Co. Ltd., , Hachioji Flächenheizelement zur Verwendung bei Spiegeln
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5783208A (en) * 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
US5891472A (en) * 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
US5891467A (en) * 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
US6726925B1 (en) * 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
DE69825495T2 (de) * 1998-12-23 2005-07-28 Idea Ag Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
US6562370B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
JP2002063747A (ja) * 2000-08-18 2002-02-28 Sony Corp 記録媒体および記録媒体原盤ならびに記録媒体の製造方法
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
GB0417494D0 (en) * 2004-08-05 2004-09-08 Glaxosmithkline Biolog Sa Vaccine

Also Published As

Publication number Publication date
US20080311184A1 (en) 2008-12-18
NO20003287L (no) 2000-08-23
CN1192766C (zh) 2005-03-16
EP1039880A1 (en) 2000-10-04
US20080279815A1 (en) 2008-11-13
WO2000024377A1 (en) 2000-05-04
CN1283107A (zh) 2001-02-07
AU765385B2 (en) 2003-09-18
AU1435099A (en) 2000-05-15
AU765385C (en) 2004-05-20
HUP0102741A3 (en) 2002-12-28
HK1032745A1 (en) 2001-08-03
JP4838936B2 (ja) 2011-12-14
KR100464601B1 (ko) 2004-12-31
JP2002528406A (ja) 2002-09-03
CA2309633A1 (en) 2000-05-04
BR9814415A (pt) 2000-10-10
KR20010033518A (ko) 2001-04-25
HUP0102741A2 (hu) 2002-03-28
MXPA00006196A (es) 2003-07-21
CA2309633C (en) 2010-12-14

Similar Documents

Publication Publication Date Title
NO20003287D0 (no) FremgangsmÕte for Õ utvikle, teste og anvende assosieringer av makromolekyler og kompleksaggregater for forbedret last og regulerbare de/assosieringshastigheter
NO20021571D0 (no) Apparat og fremgangsmåte for bestemmelse av egenskaper for en oljebrönn-utströmning, for uhomogene strömningsforhold
DK1012195T3 (da) Fremgangsmåde og apparat til gasfasepolymerisering
NO20032147L (no) Fremgangsmåte og apparat for LWD-måling av skj¶r-lydhastighet
NO20006492D0 (no) Innretning for testing av fluidpröver og fremgangsmåte til fremstilling av samme
NO20022826L (no) Fremgangsmåte og apparat for forbedring av den vertikale opplösningen av NMR-logger
NO902232D0 (no) Fremgangsmaate og apparat for proevetaking og testing av jordformasjoner.
DE69604810D1 (de) Halbleiter-wafer test und burn-in
NO20020203D0 (no) Fremgangsmåte og apparat for bestemmelse av underjordiske reservoarers egenskaper
NO973794D0 (no) Innretning og fremgangsmåte for testing
DE69824099D1 (de) Analytisches verfahren, testsatz und vorrichtung
NO985822D0 (no) System for Õ mÕle og analysere HLR parametere for anvendelse med og av en ekstern defibrillator
FI990559A0 (fi) Näytteenkäsittelymenetelmä ja diagnostinen mittauslaite
NO993603D0 (no) Fremgangsmåte og innretning for å måle materialers eller strukturers egenskaper
FI970260L (fi) Progesteroniantagonisti ja gestageeni endometrioosin ja leiomyomata uterin hoitamiseksi
DE69632464D1 (de) Messgerät und Messverfahren für die Einstellung von Prüfungs-/Messparametern
DE69626056D1 (de) Kalibrierverfahren für eine NDIR-Apparatur und Kalibriervorrichtung
NO981996D0 (no) Bµrbart apparat for testing av fruktbarhet
BR0013298A (pt) Métodos para simultaneamente detectar ambos os membros de um par de ligação
DE69916716D1 (de) Polarimeter und zugehöriges messverfahren
NO893906L (no) Fremgangsmaate og apparat for testing og kalibrering av enelektromagnetisk loggesonde.
NO993593D0 (no) Fremgangsmåte og innretning for rask måling av resistivitetsindeksen til faste proever, slik som stein
DE60027978D1 (de) Gasanalysegerät und Kalibrierverfahren dafür
NO975101D0 (no) Apparat for kalibrering av gassmålere
FI990888A0 (fi) Menetelmä ja testikittejä respiratorisen alueen tulehduksen läsnäolon ja vaikeusasteen arvioimiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application